FDA approves Glenmark Generics, LVT to manufacture Oxycodone Hydrochloride
The approved Oxycodone product line includes a 5mg capsule and 100mg/5ml oral solution. In addition to that Glenmark Generics and LVT have also signed a new supply and
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
During the conference – ‘Rare neurological diseases of childhood,’ the participants endorsed a ‘Declaration of Principles’ launching a new initiative to increase research into rare neurological diseases and
The collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible clean-room technology. The collaboration will offer comprehensive GMP manufacturing solutions